Amundi Sana Biotechnology, Inc. Transaction History

Amundi

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.11 - $4.92 $60,514 - $95,733	-19,458 Reduced 71.17%	7,881 $25,000
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $62,071 - $125,698	19,458 Added 246.9%	27,339 $107,000
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $43,975 - $71,244	7,881 New	7,881 $49,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $42,061 - $95,454	-10,209 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $53,495 - $159,056	10,209 New	10,209 $89,000

178

122M

1.77M

901K

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $555M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.